Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Lead Up To Kavanaugh Confirmation, Opposition Cites Judge’s Stance On Reproductive Issues, Health Care

Executive Summary

Brett Kavanaugh’s Supreme Court bid is being questioned by Democratic Senators – and by some lawmakers sitting on the Senate’s Judiciary Committee – due to his positions on reproductive rights and health care, including policies regarding coverage of preexisting conditions that medtech firms support. On Aug. 24, Judiciary panel Democrats called for postponement of his planned Sept. 4 confirmation hearing, in part because Kavanaugh has said in the past that a sitting US president should not be investigated for criminal charges.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT123185

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel